Senate LDA lobbying filing
ABBOTT LABORATORIES
Reported income
not reported
Reported expenses
$1.13M
Tracked program mentions1
Quoted activity text is clipped to a short extract; each filing’s full description is under Lobbying activities below.
S. 1000/H.R. 1835 Saving Access to Laboratory Services Act. Proposals regarding PAMA regulations and changes to…
Lobbying activities7
AgricultureAGR
H.R. 2300 To ensure national uniformity with respect to certain requirements relating to preterm infant formula, and for other purposes. Proposals related to access to infant formula.
Health IssuesHCR
S. 2477/H.R. 1770 Equitable Community Access to Pharmacist Services Act. S. 2922/H.R. 7164 Advancing Research for Chronic Pain Act of 2024. Proposals related to digital health technologies and innovations. Proposals to advance policies related to effective pain management. Proposals related to the President's Emergency Plan for AIDS Relief (PEPFAR).
Law Enforcement/Crime/Criminal JusticeLAW
Proposals related to third party litigation reform.
Medicare/MedicaidMMM
S. 1000/H.R. 1835 Saving Access to Laboratory Services Act. Proposals regarding PAMA regulations and changes to modernize and update the Clinical Laboratory Fee Schedule. Proposals related to Medicare coverage of continuous glucose monitors.
Tariff (miscellaneous tariff bills)TAR
Proposals related to tariffs on products imported into the United States. Proposals regarding US-China trade negotiations.
Taxation/Internal Revenue CodeTAX
Proposals to reform domestic and international tax structures.
Trade (domestic/foreign)TRD
Proposals related to U.S. global health programs and pandemic preparedness. Proposals to advance global virus surveillance.
Lobbyists6
- AUSTIN BURNES
- BETH NELSON
- DEVON FOLTZ
- MATTHEW APPLE
- SETH RADUS
- THOMAS EVERS
Source: U.S. Senate Lobbying Disclosure Act database. Dollar figures (underlined) cite the filing record on lda.senate.gov — click to view the citation. Amounts shown as “not reported” are absent from the filing itself.